Smart Syringes Market Size, Share, and Trends 2025 to 2034

Smart Syringes Market Size and Forecast 2025 to 2034

The global smart syringes market size was estimated at USD 10.54 billion in 2024 and is anticipated to reach around USD 27.85 billion by 2034, expanding at a CAGR of 10.20% from 2025 to 2034. With the growing geriatric population, to protect clinics or hospitals from infection, and increase awareness regarding vaccination. 

Smart Syringes Market Key Takeaways

• North America dominated the smart syringe market with the largest market share of 39% in 2024.
• Asia Pacific is expected to expand at a solid CAGR during the forecast period.
• By product, the auto disable syringes segment accounted for the highest market share of 65% in 2024.
• by application, the drug delivery segment generated the biggest market share in 2024. 
• by application, the vaccination segment is projected to grow at a notable CAGR during the forecast period.
• By end-user, the  hospitals segment dominated the global market in 2024. 
• By end-user, the diabetic patients segment is expanding at a solid CAGR during the forecast period.

Role of AI in the Smart Syringes 

AI plays a huge role in the smart syringes market as it helps in continuous evolution by improving its functionality, streamlining the delivery of healthcare products, and enhancing the safety of the product. It ensures the needle insertion process accuracy by pointing to the correct placement as it can optimize the depth, timing, and angle of insertion. It enhances the market demand by precise release of the dose of the medicine. 

U.S. Smart Syringes Market Size and Growth 2025 to 2034

The U.S. smart syringes market size was evaluated at USD 2.88 billion in 2024 and is predicted to be worth around USD 7.76 billion by 2034, rising at a CAGR of 10.27% from 2025 to 2034.

North America was the leading smart syringes market in 2024. The region is characterized by the increased demand for the advanced technologies in the healthcare sector. Moreover, the increased awareness regarding the blood-borne diseases owing to the unsafe injecting practices is a major factor that spurred the demand for the smart syringes in North America. North America accounted for over 39% of the market share in 2024. Moreover, the increased prevalence of chronic diseases and presence of considerable number of geriatric people in the region coupled with the increased healthcare expenditure is further fueling the demand for the smart syringes across North America.

Asia Pacific is estimated to be the most opportunistic market during the forecast period. The rising government and corporate expenditure in the development of smart healthcare infrastructure along with the rising focus in providing enhanced patient care is boosting the growth of the Asia Pacific smart syringes market. Moreover, the rising disposable income of the consumers, growing healthcare expenditure, and rising awareness regarding the needle stick injuries is expected to augment the growth of the smart syringes market in the forthcoming years.

Smart Syringes Market Growth Factors

• The smart syringes perfectly serve the need for safe injection practices by eliminating the re-use of syringes. 
• The growing demand for minimally invasive procedures among the population is boosting the demand for smart syringes. The smart syringes prevent the injuries that are associated with the needle sticks of the traditional injections. 
• It also eliminates the spread of certain blood-borne diseases such as HIV, hepatitis B, and hepatitis C. 
• The rising applications of smart syringes for various applications like vaccination, collection of blood specimens, and drug delivery are augmenting the demand for smart syringes across the globe. The recommendations of the World Health Organization to adopt the use of smart syringes to avoid needle stick injuries and promote good injection practices all over the globe are spurring the growth of the global smart syringes market.
• The rising prevalence of blood-borne diseases due to unsafe injection practices has significantly boosted the growth of the global smart syringes market.  
• The rising adoption of smart syringes amongst health maintenance organizations (HMOs) and hospitals across the globe is fueling the growth of the smart syringes market. 
• Further, diabetic patients and psychiatrists are now increasingly adopting the use of smart syringes to avoid needle stick injuries.

Market Scope

Product Insights

The auto disable syringes segment accounted for the highest market share of 65% in 2024. The auto disable syringes are the most preferred type of smart syringes across the hospitals and the health maintenance organizations as they are single-use syringes and cannot be utilized for re-use. The extensive usage of the auto disable syringes in the routine administration of drugs to the patients. Hence, this segment is dominant. The safety mechanism of these syringes prevents the transmission of blood-borne diseases and hence the most important need of the smart syringes is served.

On the other hand, the passive safety syringes is estimated to be the most opportunistic segment during the forecast period. The increased safety, auto-activation of the safety features, and the convenience associated with use of the passive safety syringes is expected to drive the growth of this segment. The rising awareness regarding the benefits of the passive safety syringes among the diabetic population further estimated to spur its demand across the globe.

Application Insights

The drug delivery was the dominant segment in 2024. The increased adoption of the smart syringes as a drug delivery device across the hospitals and clinics has augmented the demand for the smart syringes. The rising prevalence of various chronic diseases is boosting the use of the smart syringes as it serves a good mode of drug delivery and also the absorption of drugs through the injections is high, which boosts the growth of this segment.

The vaccination segment is expected to be the fastest-growing market during the forecast period. The rising burden of various infectious diseases across the globe and the constant research and developmental activities by the vaccine producing organizations is expected to fuel the growth of this segment in the forthcoming years.

End User Insights

The hospitals segment dominated the global smart syringes market in 2024. This is attributed to the increased adoption of the smart syringes in the hospitals. The rising incidences of the needle stick injuries and growing transmission of the blood borne disease is boosting the need for the safe injection practices across the hospitals.

The diabetic patients is estimated to be the fastest-growing segment during the forecast period. The diabetic patients are increasing at an alarming rate. The diabetic patients regularly needs to take insulin in order to control and manage the blood glucose levels. Hence, the demand for the smart syringes among the diabetic patients is significantly growing.

Some of the prominent players in the global smart syringes market include:

• Becton, Dickinson and Company
• Gerresheimer AG
• Baxter
• Terumo Corporation
• B. Braun Melsungen AG
• AdvaCare Pharma
• Cardinal Health
• Parker Hannifin Corp.
• Numedico Technologies Pty Ltd
• Retractable Technologies, Inc.

Recent Developments

• In April 2024, the Hindustan Syringes and Medical Devices (HMD) announced the launch of the most innovative and first-of-its-kind Dispojekt syringes with safety needles.
• In March 2024, Ypsomed announced the launch of insulin pen needle and blood sugar monitoring operations. 

Segments Covered in the Report

By Product

• Auto Disable Syringes
• Passive Safety Syringes
• Active Safety Syringes

By Application

• Vaccination
• Drug Delivery
• Blood Specimen Collection

By End User

• Hospitals
• Psychiatrics
• Family Practices
• Diabetic Patients
• Others

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of the World